Holen Sie sich die Stockscreener-App
1.38
2.82%
-0.04
Evotec Se Adr Aktie (EVO) Neueste Nachrichten
A €2.5109-per-share block trade ends an investment in Evotec SE (EVO). - Stock Titan
BIO-Europe 2026 to Convene Global Biopharma Decision-Makers in Cologne - GlobeNewswire Inc.
Evotec SE (NASDAQ: EVO) Initiates First Human Trial for JST-018 Under 2023 Accelerated Antibodies Contract - Kalkine Media
Evotec starts Phase 1 trial for JST-018 antibody therapy - grafa.com
Drug Repurposing Market to Reach USD 50.91 Billion by 2035, Expanding at 3.93% CAGR | SNS Insider - GlobeNewswire Inc.
EVO Q2 2026 Earnings: Sharply Narrower $0.26 per-ADS Loss Beats Forecast, Yet Stock Falls 4.26%Earnings Manipulation Risk - dars.gov.et
EVO Q2 2026 Earnings: Sharply Narrower $0.26 per-ADS Loss Beats Forecast, Yet Stock Falls 4.26%Cash Flow Report - dars.gov.et
Evotec SE (EVO) Rebounds 2.12% as Shares Approach Key $2.03 ResistanceFloat Adjusted Cap - dars.gov.et
Evotec SE (EVO) Rebounds 2.12% as Shares Approach Key $2.03 ResistanceDaily Profile - careplusvn.com
EVO Q1 2026 Earnings: Wider-than-Expected Loss Despite Stock RiseNet Income Trends - dars.gov.et
Evotec SE (EVO) Rebounds 2.12% as Shares Approach Key $2.03 ResistanceLast Point Resistance - dars.gov.et
EVO Q1 2026 Earnings: Wider-than-Expected Loss Despite Stock RiseSurprise Factor Analysis - www.dars.gov.et
Evotec stock struggles after profit warning as Q2 2026 figures and guidance cuts weigh on sentiment - ad-hoc-news.de
Evotec (EVO) Quarterly Figures: The Available Earnings Metric Delivers a Miss for the Current Session; Closing Reaction: The Stock Loses 1.53% in Latest TradingPre-Earnings Setup - dars.gov.et
Evotec stock trades close to 52-week low as Q2 revenue declines - ad-hoc-news.de
Evotec (EVO) Momentum: Loses 3.03% to Close at $1.92 in Latest Trading; Chart Watch: Price Remains Between $1.82 Support and $2.02 Resistance for the Current SessionMomentum ETF - dars.gov.et
Evotec (EVO) Financial Update: The EPS Result Is Below Expectation in the Latest Session; Share Response: The Stock Ends Up 3.66% in the Latest ReadingProfit Cycle Analysis - careplusvn.com
Evotec (EVO) Earnings Snapshot: The EPS Result Is Below Expectation in the Latest Session; Stock Move: The Market Price Declines 3.03% in Latest TradingAnalyst Drop Coverage - careplusvn.com
Evotec (EVO) Financial Update: The EPS Result Is Below Expectation in the Latest Session; Share Response: The Stock Ends Up 3.66% in the Latest ReadingEarnings Season Review - dars.gov.et
Evotec (EVO) Momentum: Loses 3.03% to Close at $1.92 in Latest Trading; Chart Watch: Price Remains Between $1.82 Support and $2.02 Resistance for the Current SessionLow Volume Node - www.dars.gov.et
Evotec (EVO) Momentum: Loses 3.03% to Close at $1.92 in Latest Trading; Chart Watch: Price Remains Between $1.82 Support and $2.02 Resistance for the Current SessionScalping Stock Signals - www.dars.gov.et
Evotec (EVO) Financial Update: The EPS Result Is Below Expectation in the Latest Session; Share Response: The Stock Ends Up 3.66% in the Latest ReadingReturn On Assets - www.dars.gov.et
Evotec stock trades at a discount to recent analyst targets as Xetra shares retreat - ad-hoc-news.de
Evotec stock trades well below analyst targets as selling pressure intensifies - Ad-hoc-news.de
Evotec stock faces earnings estimate cut as ADR trades below $2 - ad-hoc-news.de
Evotec (EVO) Earnings Brief: EPS Comes in Below Forecast on the Day; Market Follow-Through: Shares Move 2.55% DownEarnings Cycle Report - dars.gov.et
Evotec (EVO) Earnings Brief: EPS Comes in Below Forecast on the Day; Market Follow-Through: Shares Move 2.55% DownEstimate Revision Count - dars.gov.et
Evotec AG Earnings Call: Weak 2026, Pipeline Hopes - The Globe and Mail
Evotec stock weakens after Q2 2026 miss and guidance cut - AD HOC NEWS
Evotec SE (EVO) Rebounds 4% to $2.08 as Drug Discovery Sector StabilizesETF NAV Deviation - careplusvn.com
Evotec signs AI drug discovery partnership with Odyssey - grafa.com
Evotec SE (EVO) Holds Near $1.95 as Shares Consolidate Above Key SupportFactor ETF Flow - dars.gov.et
Evotec SE (EVO) Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock DeclinesPost-Earnings Reaction - vinanet.vn
Evotec SE (EVO) Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Stock DeclinesSaaS Earnings Trends - dars.gov.et
Berenberg cuts Evotec on delayed pharma deals clouding revenue outlook - Investing.com
Berenberg cuts Evotec stock rating on guidance downgrade By Investing.com - Investing.com Nigeria
Berenberg cuts Evotec stock rating on guidance downgrade - Investing.com
Berenberg cuts Evotec stock rating on guidance downgrade By Investing.com - Investing.com Canada
symbol__ Stock Quote Price and Forecast - CNN
TD Cowen cuts Evotec on customer delays clouding growth outlook By Investing.com - Investing.com Nigeria
TD Cowen cuts Evotec on customer delays clouding growth outlook - Investing.com
H.C. Wainwright cuts Evotec stock price target on revenue guidance reduction - Investing.com
Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session - Sahm
TD Cowen cuts Evotec stock rating on revenue delays, lowers target to $2 - Investing.com Nigeria
TD Cowen cuts Evotec stock rating on revenue delays, lowers target to $2 - Investing.com
TD Cowen cuts Evotec stock rating on revenue delays, lowers target to $2 - Investing.com Canada
Evotec (EVO) Slips Over 6% as Shares Test Key Support at $1.91Weak Sell Signals - careplusvn.com
Evotec (EVO) Slips Over 6% as Shares Test Key Support at $1.91Gap Up Stocks - dars.gov.et
Evotec (EVO) Slips Over 6% as Shares Test Key Support at $1.91Standard Deviation - www.dars.gov.et
Earnings call transcript: Evotec cuts 2026 outlook as Q2 revenue falls - Investing.com Nigeria
6.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):